Tech Company Financing Transactions
Cytovance Biologics Funding Round
Cytovance Biologics secured a $22.5 million funding round on 3/15/2011. Backers included Great Point Partners.
Transaction Overview
Company Name
Announced On
3/15/2011
Transaction Type
Venture Equity
Amount
$22,500,000
Round
Undisclosed
Investors
Great Point Partners (Jeffrey Jay)
Proceeds Purpose
The equity investment from Great Point Partners will enable Cytovance to meet growing client demand for clinical trial and commercial scale cGMP manufacturing by funding facility, service and personnel expansion at its advanced research and manufacturing operation in Oklahoma City.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
840 Research Pkwy. 200
Oklahoma City, OK 73104
USA
Oklahoma City, OK 73104
USA
Phone
Website
Email Address
Overview
biopharmaceutical contract manufacturing of therapeutic proteins and antibodies
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Yan Wang
Vice President
Naomi Seresinhe
VP - Human Resources
Joyce Johnson
VP - Manufacturing
Michael O'Mara
VP - R & D
Jesse McCool
Browse more venture capital transactions:
Prev: 3/15/2011: Minerva Surgical venture capital transaction
Next: 3/16/2011: Legolas Media venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs